Travelers Companies stock hits all-time high at 279.24 USD

Published 04/09/2025, 14:40
Travelers Companies stock hits all-time high at 279.24 USD

Travelers Companies stock reached an all-time high of 279.24 USD, marking a significant milestone for the $62.8 billion insurance giant. According to InvestingPro analysis, the company’s current valuation suggests it remains undervalued despite the recent peak. This new peak reflects a strong performance over the past year, with the stock delivering a 21.5% total return. Trading at an attractive P/E ratio of 12, the company’s robust financial results and strategic initiatives have contributed to this upward trajectory. InvestingPro data reveals the company has maintained dividend payments for 23 consecutive years, with 19 years of consecutive increases, demonstrating remarkable financial stability and shareholder commitment. As Travelers Companies continues to innovate and expand its market presence, its stock performance remains a focal point for investors looking to capitalize on its growth potential. With 8 more exclusive ProTips and comprehensive analysis available on InvestingPro, investors can access deeper insights into this prominent insurance industry player.

In other recent news, Travelers Companies reported impressive financial results for the second quarter of 2025. The company achieved earnings per share (EPS) of $6.51, significantly surpassing the forecasted $3.60, which represents an 80.83% surprise. Revenue also exceeded expectations, totaling $12.12 billion compared to the anticipated $11.62 billion. These results have prompted Goldman Sachs to raise its price target for Travelers from $312 to $320, maintaining a Buy rating due to the strong underwriting-driven earnings beat. Additionally, Citizens JMP analyst Meyer Shields reiterated a Market Perform rating on the stock, noting the insurer’s better-than-expected performance. Travelers’ core combined ratio was reported at 91%, outperforming the expected 99%. These developments highlight the company’s robust financial health and positive outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.